Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Pharma/Biotech Companies - In the News
>
Actuate raises $22M to expand GSK-3β cancer trial
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="cafead, post: 6230729, member: 1"]via Actuate Therapeutics has raised $21.7 million to take its lead oncology asset deeper into the clinic. The series B round comes shortly after Actuate dosed the first patient in a phase 1/2 trial of glycogen synthase kinase‐3 beta (GSK-3β) 9-ING-41.</p><p><br /></p><p><a href="http://bit.ly/2JrC3ke" target="_blank" class="externalLink ProxyLink" data-proxy-href="http://bit.ly/2JrC3ke" rel="nofollow">article source</a>[/QUOTE]</p><p><br /></p>
[QUOTE="cafead, post: 6230729, member: 1"]via Actuate Therapeutics has raised $21.7 million to take its lead oncology asset deeper into the clinic. The series B round comes shortly after Actuate dosed the first patient in a phase 1/2 trial of glycogen synthase kinase‐3 beta (GSK-3β) 9-ING-41. [url="http://bit.ly/2JrC3ke"]article source[/url][/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Pharma/Biotech Companies - In the News
>
Actuate raises $22M to expand GSK-3β cancer trial
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Pharma/Biotech Companies - In the News
>
Actuate raises $22M to expand GSK-3β cancer trial
>